Background: Calcium is a major component of mineralized tissues and is required for normal growth and maintenance of bone. Epidemiologic studies showed that a large percentage of the population fails to meet the currently recommended guidelines for optimal calcium intake. Objective: The present study was designed to determine whether high-calcium mineral water is an efficient additional source of dietary calcium. Design: Twelve healthy young men (mean ± SD age: 21.1 ± 1.2 y) ingested in a randomized order either 0.5 L of a mineral water containing 344 mg Ca/L or 0.5 L of a mineral water with a very low concentration of calcium (< 10 mg/L) as a control. Blood samples were drawn before and 1, 2, 3, and 4 h after intake of the water. Urine was collected for 2 h before and every 2 h for 4 h after ingestion of the water. Serum concentrations of intact parathyroid hormone (iPTH) and serum concentrations and urinary excretion of a recently developed biochemical marker of bone resorption, type 1 collagen cross-linked C-telopeptide (CTx), were measured. Results: Serum iPTH was significantly (P < 0.002) lower after ingestion of high-calcium water than after ingestion of the control. There was a significant (P = 0.01) progressive decrease in urinary CTx after ingestion of the high-calcium water, whereas after ingestion of low-calcium water the changes were modest and not significant. The fall in serum CTx concentrations was 34.7% 3 h after ingestion of high-calcium water, compared with 17.6% with the control. The decreases in serum CTx concentrations were significantly (P < 0.05) lower 1, 2, 3, and 4 h after ingestion of high-calcium water than after ingestion of the control.
INTRODUCTION
A sufficient calcium intake is now considered to be beneficial to bone mass at all stages of life and some recommended dietary allowances (RDAs) for calcium are between 1200 and 1500 mg/d for adolescents, pregnant and nursing women, and people aged ≥ 65 y (1) . To attain the optimal calcium intake it has been suggested that the frequency of consumption of dairy products and calcium-rich vegetables be increased. Other low-energy calcium sources, not mentioned in the National Institutes of Health Consensus Statement (1) , are high-calcium mineral waters. The bioavailability of calcium from mineral waters was recently studied and was found to be at least equal to that from milk (2, 3) . Oral intake of a calcium load increases serum calcium and lowers intact parathyroid hormone (iPTH) concentrations. Because elevated concentrations of iPTH induce an increase in bone turnover, which is accompanied by increased bone loss, it is pertinent to determine whether an oral calcium load not only decreases iPTH secretion but also inhibits bone resorption. The products of degradation of collagen are potential bone-resorption markers and specific amino acid sequences of nitrogen-or carbon-terminal telopeptides have been used as markers of type 1 collagen breakdown. We decided, therefore, to assess the acute effects of a low (172 mg) dose of calcium contained in 0.5 L of a high-calcium mineral water on parathyroid function and bone resorption. Bone resorption was assessed by measuring serum concentrations and urinary excretion of type 1 collagen crosslinked C-telopeptide (CTx) by using a recently developed assay.
SUBJECTS AND METHODS
Twelve healthy young men (mean ± SD age: 21.1 ± 1.2 y) were studied. None of the men had disorders or was taking medications known to affect calcium metabolism. The subjects were studied during their usual diet (dietary calcium intake of Ϸ800 mg/d) except on the evening before the assay, on which they avoided all calcium-rich meals. The subjects' vitamin D status, assessed by measuring 25-hydroxyvitamin D, was found to be replete (29 ± 5.8 g/L). All subjects were medical students and all gave their informed consent to the procedures, which were approved by the local ethics committee (Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale). The study protocol was performed between 0700 and 1300. The subjects fasted from the previous evening (2100-2200) until the end of the assay (1300). Blood samples were drawn before and 1, 2, 3, and 4 h after oral intake of the high-calcium mineral water (referred to hereafter as P0, P1 h, P2 h, P3 h, and P4 h). Urine was collected for 2 h before and every 2 h for 4 h after calcium intake (referred to hereafter as U0, U2 h, and U4 h). The test was started by having the subjects ingest 0.5 L of a high-calcium mineral water containing 172 mg elemental Ca. A control test was performed by having the subjects ingest the same volume of a low-calcium mineral water (< 10 mg/L). The 2 tests were performed at least weekly and the order of the tests was randomized.
The composition of the 2 mineral waters was as follows: 1) High-calcium mineral water: calcium, 344. Serum ionized calcium was measured with a specific calcium electrode (ICa 2 ionized calcium analyzer; Radiometer, Copenhagen). Serum PTH (1-84) was measured by immunoradiometric assay for iPTH (Nichols Institute, San Juan Capistrano, CA); intraassay variation was < 4% and interassay variation was < 6% in the explored range of concentrations. Urinary calcium was determined by using a fluorimetric method with calcein and an automatic apparatus (Precision Systems Inc, Sudbury, MA). Urinary CTx was measured with an enzyme immunoassay kit (CrossLapsEIA purchased from CIS Bio International, Gif-surYvette, France). This kit measures an amino acid sequence (EKAHDGGR) specific for a part of the C-telopeptide of the ␣-1 chain of type I collagen, the major form of collagen in organic matrix of bone that therefore can be used in the estimation of bone resorption. The assay has no cross-reaction with urinary free cross-links. The values were corrected by the urinary creatinine concentration measured by a colorimetric method. Intraassay variation is 6% and interassay variation is < 10% in the explored range of concentrations. Serum CTx was measured by using a one-step enzyme immunologic test (Serum CrossLaps; Osteometer Biotech A/S, Denmark, purchased from CIS Bio International). This test recognizes 2 cross-linked amino acid sequences of EKAHD-␤-GGR where the aspartic acid residue is ␤-isomerized. Intraassay variation is < 5% and interassay variation is < 10% in the explored range of concentrations.
Data are expressed as means ± SDs unless otherwise stated. Repeated-measures two-factor analysis of variance with interaction was performed by using the general linear models procedure (4). The main effects were time of sampling and treatment (highcalcium water or low-calcium water), with subjects as a random factor. When the time-by-treatment interaction was significant (P < 0.05), Bonferroni t tests of differences between means were performed at the global level of probability of 0.05.
RESULTS
Calcium metabolism results are shown in Table 1 . Ingestion of high-calcium water induced a significant increase in both ionized calcium (repeated-measures two-factor analysis of variance: time, P < 0.003; treatment, P < 0.005; time-by-treatment interaction, P < 0.02) and urinary calcium (time, P < 0.06; treatment, P < 0.001; time-by-treatment interaction, P < 0.004). After the subjects ingested high-calcium water, serum iPTH decreased significantly (time, P < 0.01; treatment, P < 0.002; time-bytreatment interaction, P = 0.0541), was lowest at P1 h (Ϫ34% of basal values), and returned to baseline at P4 h (Figure 1) . After 2 Significantly different from low-calcium water, P < 0.05 (Bonferroni t test).
FIGURE 1.
Time course of changes in mean (± SEM) intact parathyroid hormone (iPTH) after ingestion of 0.5 L high-calcium (172 mg Ca) and low-calcium (< 5 mg Ca) mineral water. Serum iPTH was measured before (P0) and 1 h (P1 h), 2 h (2P h), 3 h (P3 h), and 4 h (P4 h) after ingestion of water. Time and treatment main effects were significant (P < 0.01 and P < 0.002, respectively) by repeated-measures two-factor ANOVA.
ingestion of high-calcium water there was a significant (time, P < 0.02; treatment, P = 0.01; time-by-treatment interaction; P < 0.04) progressive decrease (Ϫ17% at U2 h and Ϫ34% at U4 h) in urinary CTx excretions, whereas after ingestion of lowcalcium water the changes were modest (Figure 2) . At U4 h the urinary excretion of CTx was significantly (P < 0.05) less after ingestion of high-calcium water than after ingestion of the control (Bonferroni t tests). A decrease in serum CTx concentrations (Ϫ28.9% at P2 h, Ϫ34.7% at P3 h, and Ϫ31.8% at P4 h) was evident after ingestion of high-calcium water (Figure 3) . In the control assay a more modest (Ϫ10.8% at P2 h, Ϫ17.6% at P3 h, and Ϫ15.1% at P4 h) decrease was observed. Repeated-measures two-factor analysis of variance indicated that the effects of both time and treatment on serum CTx were significant (P < 0.001) and that there was a significant (P < 0.007) interaction between the 2 main effects. The comparison of the 2 series of assays by Bonferroni t tests showed that at P1 h, P2 h, P3 h, and P4 h the serum CTx concentrations were significantly (P < 0.05) lower after ingestion of high-calcium water than after ingestion of lowcalcium water (Figure 3 ). The basal (P0) values in the 2 series of assays were not significantly different.
DISCUSSION
We showed, for the first time, that a low dose (172 mg) of calcium contained in 0.5 L mineral water and given to young men inhibited iPTH secretion by 34% 1 h after ingestion and induced a significant decrease in CTx both in urine (Ϫ34% between 2 and 4 h) and in serum (Ϫ34.7% at 3 h); this decrease was probably mediated by the reduction in iPTH secretion. Previous studies showed that calcium supplements administered at various times suppressed PTH secretion and decreased bone resorption markers. A significant decrease in PTH and resorption bone markers was observed after supplements of calcium ingested for days (5, 6) , months (7), and years (8) . Some studies showed the acute effects of the intake of calcium on serum PTH and on bone resorption in men but with much larger doses (1000 mg) and showed an inhibition by 29% of urinary deoxypyridinoline between 4 and 6 h (9) and by 55% of urinary CTx (between 2 and 4 h) after the ingestion of the calcium load (10) . We observed a significant decrease in serum CTx after ingestion of high-and low-calcium mineral water. However, the decrease in serum CTx was significantly less after ingestion of low-calcium mineral water than after ingestion of high-calcium mineral water and could be attributed to a circadian rhythm of bone resorption. No significant decrease in urinary CTx was found during the 6 h of the assay with low-calcium water, although circadian variations in urinary pyridinium cross-links, N-telopeptide, and CTx, have been reported (11, 12) .
The comparison of the effects of 500-and 1500-mg doses of calcium had suggested to us that small oral doses of calcium could be efficient in acutely inhibiting PTH secretion (13) . In a previous study we showed that 250 mg Ca contained in a calcium-rich mineral water significantly inhibited by 45% the serum concentrations of iPTH (14) . In the present study a dose of calcium as small as 172 mg contained in 0.5 L mineral water was ingested and had significant effects on both iPTH concentrations and bone resorption. We can estimate, according to Heaney et al's data (15) , that Ϸ40% of the ingested dose should have been absorbed. Studies of absorbability of calcium in different high-calcium mineral waters showed that after ingestion of 100 mg Ca, 47.5% was absorbed (2), whereas after ingestion of 1000 mg Ca 23.8 ± 4.8% was absorbed (3).
Dietary intakes of calcium are generally much less than the RDAs; to attain optimal calcium intake, calcium supplements are frequently prescribed. These supplements are often administered once daily and the duration of their effects is restricted to a few hours. If one agrees with the statement, taken from the National Institutes of Health Consensus Conference on Optimal Calcium Intake (1) , that "absorption of calcium supplements is most effi-FIGURE 2. Urinary excretion of collagen cross-linked C-telopeptide (CTx) before and after ingestion of 0.5 L of either high-calcium (172 mg Ca) or low-calcium (< 5 mg Ca) mineral water. Urine was collected for 2 h before (U0) and every 2 h for 4 h (U2 h, U4 h) after ingestion of water. x -± SEM. High-calcium and low-calcium waters were compared at each time point by using Bonferroni t tests of differences between means. * P < 0.05.
FIGURE 3.
Time course of changes in serum mean (± SEM) collagen cross-linked C-telopeptide (CTx) after ingestion of 0.5 L of either highcalcium (172 mg Ca) or low-calcium (< 5 mg Ca) mineral water. Serum CTx was measured before (P0) and 1 h (P1 h), 2 h (P2 h), 3 h (P3 h), and 4 h (P4 h) after ingestion of water. High-calcium and low-calcium waters were compared at each time point by using Bonferroni t tests of differences between means.
* P < 0.05.
cient at individual doses of 500 mg or less and when taken between meals," drinking calcium-rich mineral water several times a day could be recommended because it would provide both supplemental calcium and adequate hydration. Furthermore, better absorption of calcium by ingesting fractionate rather than single doses of calcium has been emphasized on both theoretical and practical bases (16, 17) .
In conclusion, the results of the present study showed that high-calcium mineral water not only represented an additional dietary source of calcium but also modulated parathyroid function and bone metabolism. Nevertheless, further long-term studies are needed to confirm these short-term results.
